Page 93 of 212
The roles of structural dynamics in the cellular functions of RNAs
Ganser LR, Kelly ML, Herschlag D, Al-Hashimi HM. Nat Rev Mol Cell Biol. 2019 Jun 10. PubMed
June 30, 2019
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
Wang Y, Yu RZ, Henry S, Geary RS. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):475-485. PubMed
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Shen W, De Hoyos CL, Migawa MT, Vickers TA, Sun H, Low A, Bell TA 3rd, Rahdar M, Mukhopadhyay S, Hart CE, Bell M, Riney S, Murray SF, Greenlee S, Crooke RM, Liang XH, Seth PP, Crooke ST. Nat Biotechnol. …
May 31, 2019
Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations
Huang L, Aghajan M, Quesenberry T, Low A, Murray SF, Monia BP, Guo S. Nucleic Acid Ther. 2019 May 9. PubMed
Page 93 of 212
Page 93 of 212
The roles of structural dynamics in the cellular functions of RNAs
Ganser LR, Kelly ML, Herschlag D, Al-Hashimi HM. Nat Rev Mol Cell Biol. 2019 Jun 10. PubMed
June 30, 2019
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
Wang Y, Yu RZ, Henry S, Geary RS. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):475-485. PubMed
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Shen W, De Hoyos CL, Migawa MT, Vickers TA, Sun H, Low A, Bell TA 3rd, Rahdar M, Mukhopadhyay S, Hart CE, Bell M, Riney S, Murray SF, Greenlee S, Crooke RM, Liang XH, Seth PP, Crooke ST. Nat Biotechnol. …
May 31, 2019
Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations
Huang L, Aghajan M, Quesenberry T, Low A, Murray SF, Monia BP, Guo S. Nucleic Acid Ther. 2019 May 9. PubMed
Page 93 of 212
